CHRISTINE ATKINSON: Open Payments
NPI 1407123813 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 23 payments from 8 companies in 2025. Trend: 2023 $472 · 2024 $453 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
| Teva Pharmaceuticals USA, Inc. | 4 | $109 |
| Vanda Pharmaceuticals Inc. | 4 | $103 |
| Janssen Pharmaceuticals, Inc | 3 | $78 |
| ABBVIE INC. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Alkermes, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $14 |
Products named: REXULTI, AUSTEDO XR, FANAPT, INVEGA SUSTENNA, VRAYLAR, CAPLYTA, ARISTADA.
Industry payments across FL — which companies pay providers there.
